Matches in SemOpenAlex for { <https://semopenalex.org/work/W402364771> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W402364771 abstract "1. The aim was to determine whether the angiotensin converting enzyme inhibitor perindopril, at a concentration approaching that used in human antihypertensive therapy, influences progression of preformed atherosclerotic plaques. 2. Rabbits had their right carotid artery de-endothelialized with a balloon catheter, which resulted in the formation of a myointimal thickening. 3. At 14 weeks post surgery groups I, II and III (n = 6 per group) were fed a 1% cholesterol-enriched diet for 6 weeks, then group I rabbits were sacrificed. Groups II and III were placed on a normolipidaemic diet for a further 6 weeks with group III rabbits also receiving 0.3 mg day−1 kg−1 perindopril. Groups IV and V were treated the same as groups II and III, respectively, except that they received a normal diet throughout. 4. Group I rabbits fed a 1% cholesterol-enriched diet for 6 weeks developed lipid-filled lesions covering 26.3 ± 14.3% of the surface area of the descending thoracic aorta. This was exacerbated in rabbits fed a 1% cholesterol diet for 6 weeks followed by 6 weeks on a normal diet (61.2 ± 27.3%). In rabbits fed a 1% cholesterol diet for 6 weeks then a normal diet for a further 6 weeks plus 0.3 mg day−1 kg−1 perindopril, the percentage surface area covered by lesions was 21.8 ± 15.8%. No lesions developed in the aortas of rabbits fed a normal diet. In the right coronary artery the resulting neointima in rabbits fed a 1% cholesterol diet for 6 weeks only was 42.4 ± 5.7% of the cross-sectional area of the vessel wall, 57.4 ± 8.0% in rabbits receiving 6 weeks' cholesterol diet then 6 weeks' normal diet, 36.0 ± 6.6% in rabbits fed a 6-week cholesterol diet then 6 weeks' normal diet with 0.3 mg day−1 kg−1 perindopril and 33.2 ± 4.9% and 31.8 ± 3.1% in rabbits on a normal diet throughout with 0 and 0.3 mg day−1 kg−1 perindopril respectively. The cellular composition of the lesions was also altered in perindopril-treated animals, with fewer and smaller fat-filled cells surrounded by more extracellular matrix. 5. Perindopril is effective in preventing progression of existing atherosclerotic lesions in the cholesterol-fed rabbit after 6 weeks on a normal diet." @default.
- W402364771 created "2016-06-24" @default.
- W402364771 creator A5016010497 @default.
- W402364771 creator A5033433137 @default.
- W402364771 creator A5059311316 @default.
- W402364771 date "1994-12-01" @default.
- W402364771 modified "2023-09-26" @default.
- W402364771 title "An Angiotensin Converting Enzyme Inhibitor, Perindopril, Prevents Progression of Preformed Atherosclerotic Lesions in the Cholesterol-Fed Rabbit" @default.
- W402364771 doi "https://doi.org/10.1042/cs0870685" @default.
- W402364771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7874860" @default.
- W402364771 hasPublicationYear "1994" @default.
- W402364771 type Work @default.
- W402364771 sameAs 402364771 @default.
- W402364771 citedByCount "11" @default.
- W402364771 countsByYear W4023647712019 @default.
- W402364771 crossrefType "journal-article" @default.
- W402364771 hasAuthorship W402364771A5016010497 @default.
- W402364771 hasAuthorship W402364771A5033433137 @default.
- W402364771 hasAuthorship W402364771A5059311316 @default.
- W402364771 hasConcept C126322002 @default.
- W402364771 hasConcept C134018914 @default.
- W402364771 hasConcept C139059822 @default.
- W402364771 hasConcept C27016395 @default.
- W402364771 hasConcept C2776393769 @default.
- W402364771 hasConcept C2776864027 @default.
- W402364771 hasConcept C2777339539 @default.
- W402364771 hasConcept C2778163477 @default.
- W402364771 hasConcept C2778283817 @default.
- W402364771 hasConcept C2778583881 @default.
- W402364771 hasConcept C2779133491 @default.
- W402364771 hasConcept C2779200603 @default.
- W402364771 hasConcept C2779980429 @default.
- W402364771 hasConcept C2993470428 @default.
- W402364771 hasConcept C71924100 @default.
- W402364771 hasConcept C84393581 @default.
- W402364771 hasConceptScore W402364771C126322002 @default.
- W402364771 hasConceptScore W402364771C134018914 @default.
- W402364771 hasConceptScore W402364771C139059822 @default.
- W402364771 hasConceptScore W402364771C27016395 @default.
- W402364771 hasConceptScore W402364771C2776393769 @default.
- W402364771 hasConceptScore W402364771C2776864027 @default.
- W402364771 hasConceptScore W402364771C2777339539 @default.
- W402364771 hasConceptScore W402364771C2778163477 @default.
- W402364771 hasConceptScore W402364771C2778283817 @default.
- W402364771 hasConceptScore W402364771C2778583881 @default.
- W402364771 hasConceptScore W402364771C2779133491 @default.
- W402364771 hasConceptScore W402364771C2779200603 @default.
- W402364771 hasConceptScore W402364771C2779980429 @default.
- W402364771 hasConceptScore W402364771C2993470428 @default.
- W402364771 hasConceptScore W402364771C71924100 @default.
- W402364771 hasConceptScore W402364771C84393581 @default.
- W402364771 hasLocation W4023647711 @default.
- W402364771 hasLocation W4023647712 @default.
- W402364771 hasOpenAccess W402364771 @default.
- W402364771 hasPrimaryLocation W4023647711 @default.
- W402364771 hasRelatedWork W149822611 @default.
- W402364771 hasRelatedWork W1976409921 @default.
- W402364771 hasRelatedWork W1987688493 @default.
- W402364771 hasRelatedWork W2072046184 @default.
- W402364771 hasRelatedWork W2095686953 @default.
- W402364771 hasRelatedWork W2103703353 @default.
- W402364771 hasRelatedWork W2166797937 @default.
- W402364771 hasRelatedWork W2170940341 @default.
- W402364771 hasRelatedWork W2258852638 @default.
- W402364771 hasRelatedWork W402364771 @default.
- W402364771 isParatext "false" @default.
- W402364771 isRetracted "false" @default.
- W402364771 magId "402364771" @default.
- W402364771 workType "article" @default.